Loading asset research
Jade Biosciences Inc. Common Stock
JBIONasdaq · USD · StocksQuote as of · Exchange session not verified$17.83
-6.84%
Today
JBIO
Loading 1D prices…
Market cap
$1.1B
Volume
1.2M
52w high
$28.0052w low
$6.91Company profile
Jade Biosciences Inc. Common Stock
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The company also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Waltham, MA, United States
Employees
55
Fiscal year end
1231
CIK
1798749
Session & valuation
Open$19.38
Previous close$19.14
Day high$20.10
Day low$17.53
30-day avg. volume828K
Outstanding shares63.6M
Diluted EPS-$3.19
Latest annual period
P/E (trailing)-5.59
P/E (forward)-6.72
Price / book2.58
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| OPKOPKO Health Inc. Common Stock | $1.2B | $606.9M | -37186.98% | -$0.30 | +5.37% | Buy |
| OBXObsidian Therapeutics Inc. Common Stock | $1.1B | $0.00 | — | -$1.63 | +4.72% | Buy |
| APMDApnimed Inc. Common Stock | $1.1B | $38.5M | -2.42% | -$0.03 | -1.79% | Buy |
| ALMSAlumis Inc. Common Stock | $1.2B | $24.1M | -1011.75% | -$2.86 | -7.37% | Buy |
| SVRASavara Inc. Common Stock | $1.1B | $0.00 | — | -$0.53 | -0.28% | Buy |